Skip to content

Clinical trials

Phase 2 Amyotrophic Lateral Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 2 Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20055
20066
20072
20088
20095
20101
20116
20127
201311
20144
20155
20167
20179
20189
201910
202011
202116
20225
20234
20247
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Terminated18
Unknown status17
Active, not recruiting9
Recruiting9
Withdrawn9
Not yet recruiting8
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics5
Massachusetts General Hospital4
Novartis Pharmaceuticals4
Azienda Ospedaliero-Universitaria di Modena3
Clene Nanomedicine3
National Center for Research Resources (NCRR)3
Peking University Third Hospital3
American University of Beirut Medical Center2
Amylyx Pharmaceuticals Inc.2
Aquestive Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis167
Motor Neuron Disease24
Nervous System Diseases5
Neurodegenerative Diseases5
Neuromuscular Diseases5
Muscular Atrophy, Spinal4
Central Nervous System Diseases3
Multiple Sclerosis3
Nerve Degeneration3
Anxiety Disorders2

Trials

Showing 26 to 50 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.